| Nome |
# |
|
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?, file e31e124d-b6eb-987f-e053-3705fe0a095a
|
987
|
|
Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which?, file e31e124e-4f31-987f-e053-3705fe0a095a
|
528
|
|
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences., file e31e124d-7fae-987f-e053-3705fe0a095a
|
439
|
|
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma, file e31e124c-0530-987f-e053-3705fe0a095a
|
340
|
|
Male Bilateral Risk-Reducing Mastectomy: Report of a Case, file e31e124e-6f1d-987f-e053-3705fe0a095a
|
282
|
|
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?, file e31e124c-3152-987f-e053-3705fe0a095a
|
262
|
|
Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer., file e31e124d-2167-987f-e053-3705fe0a095a
|
227
|
|
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years., file e31e124b-2ed2-987f-e053-3705fe0a095a
|
226
|
|
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients., file e31e124d-83c2-987f-e053-3705fe0a095a
|
212
|
|
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life, file e31e124b-095f-987f-e053-3705fe0a095a
|
187
|
|
Ovarian cancer: can proteomics give new insights for therapy and diagnosis?, file e31e124b-2c28-987f-e053-3705fe0a095a
|
178
|
|
NUT midline carcinoma of the head and neck: current perspectives, file e31e124e-25d2-987f-e053-3705fe0a095a
|
174
|
|
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era, file e31e124f-76f2-987f-e053-3705fe0a095a
|
172
|
|
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes, file e31e124b-073f-987f-e053-3705fe0a095a
|
170
|
|
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy, file e31e124e-38a8-987f-e053-3705fe0a095a
|
155
|
|
Male mammary myofibroblastoma: Two case reports and brief review of literature, file e31e124e-6149-987f-e053-3705fe0a095a
|
155
|
|
The Role of Exosomes in Breast Cancer Diagnosis., file e31e124f-7c6a-987f-e053-3705fe0a095a
|
155
|
|
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications, file e31e124d-737e-987f-e053-3705fe0a095a
|
153
|
|
Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe, file e31e124f-f589-987f-e053-3705fe0a095a
|
151
|
|
Fertility and pregnancy issues in BRCA-mutated breast cancer patients, file e31e1250-0597-987f-e053-3705fe0a095a
|
149
|
|
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better?, file e31e124d-83c0-987f-e053-3705fe0a095a
|
140
|
|
Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial, file e31e124d-cb10-987f-e053-3705fe0a095a
|
136
|
|
Lifestyle intervention on body weight and physical activity in patients with breast cancer can reduce the risk of death in obese women: The EMILI study, file e31e124e-41c1-987f-e053-3705fe0a095a
|
133
|
|
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness, file e31e1250-6154-987f-e053-3705fe0a095a
|
131
|
|
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies, file e31e124e-0200-987f-e053-3705fe0a095a
|
116
|
|
Molecular characterization and targeted therapeutic approaches in breast cancer, file e31e124e-0574-987f-e053-3705fe0a095a
|
114
|
|
Molecular mechanisms of PARP inhibitors In BRCA-related ovarian cancer, file 75f7a227-4af2-4f0b-829b-80ed4274a522
|
95
|
|
BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study, file e31e124f-ad08-987f-e053-3705fe0a095a
|
93
|
|
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores, file e31e124e-c674-987f-e053-3705fe0a095a
|
92
|
|
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series., file e31e124f-6d6c-987f-e053-3705fe0a095a
|
91
|
|
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study, file e31e124f-c96d-987f-e053-3705fe0a095a
|
90
|
|
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials., file e31e124f-d99a-987f-e053-3705fe0a095a
|
88
|
|
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?, file e31e124d-7d97-987f-e053-3705fe0a095a
|
81
|
|
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature, file e31e124f-eaba-987f-e053-3705fe0a095a
|
80
|
|
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification, file e31e124e-faeb-987f-e053-3705fe0a095a
|
79
|
|
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers, file e31e124f-b173-987f-e053-3705fe0a095a
|
68
|
|
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation, file e31e124f-7b00-987f-e053-3705fe0a095a
|
65
|
|
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY, file e31e124f-d5b2-987f-e053-3705fe0a095a
|
63
|
|
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis, file e31e124f-f524-987f-e053-3705fe0a095a
|
52
|
|
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group, file e31e1250-7215-987f-e053-3705fe0a095a
|
46
|
|
Management of PALB2-associated breast cancer: A literature review and case report, file 331d5e16-87eb-4d5f-90d3-e6ae3bae0eee
|
45
|
|
Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial, file e31e124d-cb13-987f-e053-3705fe0a095a
|
45
|
|
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy, file 1faffc70-b523-4d8b-b4f9-d9cc34f33630
|
42
|
|
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL, file e31e124c-0457-987f-e053-3705fe0a095a
|
38
|
|
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases ., file e31e124d-83be-987f-e053-3705fe0a095a
|
36
|
|
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING MULTI-GENE PANEL, file e31e124b-f209-987f-e053-3705fe0a095a
|
32
|
|
The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance, file 5ca744c9-bd07-4a8d-a45e-9f3d76cd9d08
|
31
|
|
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores, file e31e1250-7a4d-987f-e053-3705fe0a095a
|
26
|
|
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review., file 1507e16c-2218-4472-86fc-46938f88e71c
|
23
|
|
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL, file e31e124d-6227-987f-e053-3705fe0a095a
|
19
|
|
Talking about sex: erectile dysfunction in the oncology patient, file 6396a5d5-c36c-404b-9489-376c3595f496
|
15
|
|
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center., file e31e124d-d05e-987f-e053-3705fe0a095a
|
15
|
|
Obesity in Postmenopausal Breast Cancer Patients: It Is Time to Improve Actions for a Healthier Lifestyle. The Results of a Comparison Between Two Italian Regions With Different “Presumed” Lifestyles, file e31e1250-933e-987f-e053-3705fe0a095a
|
15
|
|
Personalized Systemic Therapies in Hereditary Cancer Syndromes, file d396a84a-cf99-4853-ae20-0923b996bced
|
14
|
|
The spectrum of fancm protein truncating variants in European breast cancer cases, file eeedac55-2fcc-4e4e-960f-f729a917be89
|
14
|
|
Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study, file fd15996d-e971-405c-a501-83da31625ab1
|
14
|
|
CTC enumeration and characterization: Moving toward personalized medicine, file 43baee8e-68ec-419e-b28c-179f71b8dd4d
|
11
|
|
The prognostic and predictive role of somatic brca mutations in ovarian cancer: Results from a multicenter cohort study, file 43c8439e-f5f1-4846-a271-3e18f6ae3602
|
10
|
|
COVID-related disruption in mammographic screening: a year later., file d305da8b-c205-44a0-8ef5-c6bb916f1562
|
10
|
|
Occult breast cancer: the uncommon presentation of a common disease, file 74edb288-c5cc-44c5-9fa1-434b92160351
|
6
|
|
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials, file 236df937-b400-4e8b-bda7-a84c5e43ef11
|
5
|
|
Response to: COVID-related upsurge in diagnoses of advanced breast cancer-is a disruption in mammography screening the one to be blamed?, file f648b23e-145a-4d9d-b9a5-cf320003623d
|
5
|
|
Characterization of new ATM deletion associated with hereditary breast cancer, file e31e124f-d706-987f-e053-3705fe0a095a
|
4
|
|
Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk, file 1431a39c-851b-494d-954a-6adea9a8bff0
|
3
|
|
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women with Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial, file b939c0de-a71d-4534-88b8-8d738dca7a98
|
3
|
|
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists' perspective, file 85c5da1f-3426-4cef-bc95-1633c15fdcaa
|
2
|
|
Germline mutations in other homologous recombination repair-related genes than brca1/2: Predictive or prognostic factors?, file c0981385-3df4-4d24-b7e1-bfd56b053158
|
2
|
|
Acceptability and adherence in a chemoprevention trial among women at increased risk for breast cancer attending the Modena Familial Breast and Ovarian Cancer Center, file e31e124b-2ddf-987f-e053-3705fe0a095a
|
2
|
|
Twenty-years experience with de novo metastatic breast cancer, file e31e124b-a987-987f-e053-3705fe0a095a
|
2
|
|
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis, file e31e124e-f3ca-987f-e053-3705fe0a095a
|
2
|
|
Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines, file 401e60a7-273c-4503-b804-247462295fd3
|
1
|
|
Relative and disease-free survival for breast cancer in relation to subtype: a population-based study, file e31e124b-4578-987f-e053-3705fe0a095a
|
1
|
|
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women, file e31e124b-b66e-987f-e053-3705fe0a095a
|
1
|
|
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study, file e31e124d-73ad-987f-e053-3705fe0a095a
|
1
|
|
Fertility and pregnancy issues in BRCA-mutated breast cancer patients, file e31e124e-ceac-987f-e053-3705fe0a095a
|
1
|
|
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness, file e31e124f-7b26-987f-e053-3705fe0a095a
|
1
|
| Totale |
7.652 |
